Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis

Journal of Sichuan University (Medical Science)

Volumn 39, Issue 5, 2008, Pages 748-752

  Liu, Tong ^a   Zhang, Jian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Immunohistochemical staining; Sclerosis, systemic; V type collagen

Indexed keywords

EID: 53349164749     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest, 2007; 117(3):557-567.
2. Ruzek MC, Jha S, Ledbetter S, et al. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum, 2004; 50(4): 1319-1331.
3. Roulet M, Ruggiero F, Karsenty G, et al. A comprehensive study of the spatial and temporal expression of the col5α1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues. Cell Tissue Res, 2007; 327(2): 323-332.
4. Velosa APP, Teodoro WR, de Oliveira CC, et al. Collagen V nasal tolerance in experimental model of systemic sclerosis. Arch Dermatol Res, 2007; 299(4): 177-189.
5. Bezerra MC, Teodoro WR, de Oliveira CC, et al. Seleroderma-like remodeling induced by type V collagen. Arch Dermatol Res, 2006; 298(2): 51-57.
6. Verrecchia F, Laboureau J, Verola O, et al. Skin involvement in scleroderma - where histological and clinical scores meet. Rheumatology (Oxford), 2007; 46(5): 833-841.
7. Luparello C, David F, Campisi G, et al. T47-D cells and type V collagen : a model for the study of apoptotic gene expression by breast cancer cells. Biol Chem, 2003; 384(6):965-975.
8. Luparello C, Romanotto R, Tipa A, et al. Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells. J Bone Miner Res, 2001;16(12):2173-2181.
9. Teodoro WR, Miron BG, Tsuzuki L, et al. Synovial remodeling process induced by type V collagen immunization in rabbits. Pathol Res Pract, 2003; 199(9): 605-612.
10. Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol, 2004; 286(6): 1129-1139.
11. Rothblum K, Stahl RC, Carey DJ. Constitutive release of alpha 4 type V collagen N-terminal domain by Schwann cells and binding to cell surface and extracellular matrix heparan sulfate proteoglycans. J Biol Chem, 2004, 279 (49): 51282-51288.
12. Chanut-Delalande H, Bonod-Bidaud C, Cogne S, et al. Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol Cell Biol, 2004; 24(13): 6049-6057.
13. Wenstrup RJ, Florer JB, Brunskill EW, et al. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem, 2004; 279(51): 53331-53337.
14. Wenstrup RJ, Florer JB, Davidson JM, et al. Murine model of the Ehlers-Danlos syndrome. col5α1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem, 2006; 281(18): 12888-12895.
15. Parra ER, Teodoro WR, Velosa APP, et al. Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia. J Histochem Cytochem, 2006; 54(12): 1315-1325.
16. Laplante P, Raymond MA, Gagnon G, et al. Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J Immunol, 2005; 174(9): 5740-5749.